Therapeutic glycoproteins have taken up a significant amount of space in the biopharmaceuticals industry. The methylotrophic yeast Pichia pastoris is widely used for the production of glycoproteins in the biotechnology and biopharmaceutical industries because of its capacity to carry out posttranslational modifications (PTM) and secrete the target protein to the cultivation broth. With scientists at the Ph.D. level and more than ten years of experience producing recombinant proteins, Creative Biolabs has successfully built a glyco-engineered P. pastoris to produce high-quality glycoproteins that resemble human glycoproteins.
Learn more: Glyco-engineered Pichia pastoris Expression System
